BIOS — BioPlus Acquisition Balance Sheet
0.000.00%
Last trade - 00:00FinancialsAdventurousSmall Cap
- $271.14m
- $276.39m
Annual balance sheet for BioPlus Acquisition, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | 10-K | 10-K | |
| Standards: | — | USG | USG |
| Status: | fx Preliminary | Final | Final |
| Cash | |||
| Cash and Short Term Investments | — | 0.636 | 0.14 |
| Prepaid Expenses | |||
| Total Current Assets | — | 1 | 0.549 |
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | — | 236 | 238 |
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | — | 0.179 | 0.527 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | — | 15 | 15.3 |
| Non Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | — | 221 | 223 |
| Total Liabilities & Shareholders' Equity | — | 236 | 238 |
| Total Common Shares Outstanding |